PLIANT THERAPEUTICS, INC. Investment Income, Interest
PLIANT THERAPEUTICS, INC. (PLRX) reported Investment Income, Interest of $478.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2021-03-16
- PLIANT THERAPEUTICS, INC. investment income, interest for the quarter ending 2020-12-31 was $86.00K, a 25.22% decline year-over-year.
- PLIANT THERAPEUTICS, INC. investment income, interest for the quarter ending 2020-09-30 was $72.00K, a 51.35% decline year-over-year.
- PLIANT THERAPEUTICS, INC. investment income, interest for the quarter ending 2020-06-30 was $111.00K, a 53.75% decline year-over-year.
- PLIANT THERAPEUTICS, INC. investment income, interest for the quarter ending 2020-03-31 was $209.00K.
- PLIANT THERAPEUTICS, INC. investment income, interest for fiscal 2020 was $478.00K, a 41.42% decline from fiscal 2019.
- PLIANT THERAPEUTICS, INC. investment income, interest for fiscal 2019 was $816.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2020-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $158.00K derived: sum of 2 quarters · filed 2021-03-16 | $269.00K derived: sum of 3 quarters · filed 2021-03-16 | $478.00K 10-K · filed 2021-03-16 |
| 2020-09-30 | $72.00K 10-Q · filed 2020-11-10 | $183.00K derived: sum of 2 quarters · filed 2020-11-10 | $392.00K 10-Q · filed 2020-11-10 | $507.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-06-30 | $111.00K 10-Q · filed 2020-08-11 | $320.00K 10-Q · filed 2020-08-11 | $435.00K derived: sum of 3 quarters · filed 2021-03-16 | $583.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-03-31 | $209.00K derived: 10-K 12 month − 3 quarters · filed 2021-03-16 | $324.00K derived: sum of 2 quarters · filed 2021-03-16 | $472.00K derived: sum of 3 quarters · filed 2021-03-16 | $712.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $263.00K derived: sum of 2 quarters · filed 2021-03-16 | $503.00K derived: sum of 3 quarters · filed 2021-03-16 | $816.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $148.00K 10-Q · filed 2020-11-10 | $388.00K derived: sum of 2 quarters · filed 2020-11-10 | $701.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $240.00K 10-Q · filed 2020-08-11 | $553.00K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |